Epidemiology and carcinogenesis of hepatocellular carcinoma.
about
Association between hepatitis C and hepatocellular carcinomaSilymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinomaA statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.Colors of vegetables and fruits and the risks of colorectal cancer.Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling.Abrus agglutinin suppresses human hepatocellular carcinoma in vitro and in vivo by inducing caspase-mediated cell death.Elevated plasma gamma-tocopherol and decreased alpha-tocopherol in men are associated with inflammatory markers and decreased plasma 25-OH vitamin D.Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway.Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma.Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysisAurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model.The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion.Situs Inversus Totalis (SIT) with Hepatocellular Carcinoma (HCC): A Rare Case Report and Review of 12 Other Cases.Diffuse liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay.Molecular aspects of microcystin-induced hepatotoxicity and hepatocarcinogenesis.Malignant disease in the haemophilic population: moving towards a management consensus?Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma.Toxicopathology induced by microcystins and nodularin: a histopathological review.Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma.Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation.Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors.High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.
P2860
Q27491295-8B1154B5-BF4D-4525-81E6-BE363CF012CEQ28583022-535D2137-36E8-4F17-9328-FAC3DBD6551FQ30977795-7E154A59-03C2-46CB-B5CA-3ABFFF18212CQ33572647-3D5148CD-F2BA-40B5-89DD-FD462CD78759Q33597307-252C5D3C-8532-459E-B06D-5776CABBDDE7Q33861908-C7E7B3B2-3E58-4548-BD0D-6BE9D843C7AEQ33958517-081FE499-86CB-4863-9746-1D1564CB3D00Q35666438-3F48021D-AAE3-4D28-9BFD-5D4383E59ED2Q37002835-C47EDE73-1AE9-4154-99AE-FAA69C031981Q37037118-3B2B404E-5165-40C2-9469-428677775DC2Q37328115-ADF33102-2B19-437E-8CC6-8293519653C2Q37468111-026435D3-214E-4772-BAA6-0FDC4AE65169Q37510876-A338B056-945E-4F00-880A-9260EB673FAFQ37634131-AAFA286B-7900-4F8D-824B-8B0EFFFD9CD2Q37730716-96EA0DF0-7D20-40CE-9CBA-EAB428490DD5Q38013149-A8B538AA-518C-4695-8C70-C680442F7583Q38211814-43960E79-D664-4E59-B6C2-76A0A3BBA509Q38507269-4CC8C17F-0D4D-4DF7-BD44-0FFD5FE8CD67Q39396056-D03F1F1E-CE69-456E-B9DC-B7D8CC49A1BBQ39811440-EC87EECD-FD3A-4A4E-8766-B5D8F7C43FC2Q39889748-5C8EF6CA-A56F-4703-AC25-4A15F062CA90Q41954700-66B04831-9EFA-422B-98A7-23E3301F41BDQ44671694-325BF864-630D-4324-809F-E0F113570EDEQ46467546-06CE0080-9F60-4EF5-B163-4242DB94EBB2Q46750131-54083E90-AE1B-448B-BA72-A6F812CC3951Q55498732-ACC180DF-F95D-4912-8D79-B8C92F992F3E
P2860
Epidemiology and carcinogenesis of hepatocellular carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@ast
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@en
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@nl
type
label
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@ast
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@en
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@nl
prefLabel
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@ast
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@en
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@nl
P2860
P1476
Epidemiology and carcinogenesis of hepatocellular carcinoma.
@en
P2093
Anthony S-Y Leong
Trishe Y-M Leong
P2860
P356
10.1080/13651820410024021
P577
2005-01-01T00:00:00Z